Clinical Trials Logo

Clinical Trial Summary

This clinical trial will explore the safety and effect of GCSF-mobilized autologous ex vivo selected CD34 cells for the treatment of CMD in adults currently experiencing angina and with no obstructive coronary artery disease. Eligible subjects will receive a single intracoronary infusion of CLBS14.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03508609
Study type Interventional
Source Caladrius Biosciences, Inc.
Contact Chrissy Kotynski
Phone (908) 842-0093
Email ckotynski@caladrius.com
Status Recruiting
Phase Phase 2
Start date April 19, 2018
Completion date April 2020